Evidence map›Paper›PMID 38429579›Full record

ArticleEMBO reports2024

PHF6-mediated transcriptional control of NSC via Ephrin receptors is impaired in the intellectual disability syndrome BFLS.

Dilan Rasool, Audrey Burban, Ahmad Sharanek, Ariel Madrigal, Jinghua Hu, Keqin Yan, Dianbo Qu, Anne K Voss, Ruth S Slack, Tim Thomas and 5 more

Open access · diamondAbstract read
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Dilan RasoolDepartment of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Audrey BurbanDepartment of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Ahmad SharanekDepartment of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Ariel MadrigalDepartment of Human Genetics, McGill University, 3640 Rue University, Montréal, QC, H3A OC7, Canada.
Jinghua HuRegenerative Medicine Program and Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Keqin YanRegenerative Medicine Program and Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
Dianbo QuDepartment of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Anne K VossWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.ORCID 0000-0002-3853-9381
Ruth S SlackDepartment of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Tim ThomasWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia.ORCID 0000-0002-7623-8344
Azad BonniRoche Pharma Research and Early Development (pRED), Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
David J PickettsDepartment of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Vahab D SoleimaniDepartment of Medicine, Division of Experimental Medicine, McGill University, 1001 Decarie Boulevard, Montréal, QC, H4A 3J1, Canada.ORCID 0000-0003-2154-4894
Hamed S NajafabadiDepartment of Human Genetics, McGill University, 3640 Rue University, Montréal, QC, H3A OC7, Canada. hamed.najafabadi@mcgill.ca.ORCID 0000-0003-2735-4231
Arezu Jahani-AslDepartment of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada. arezu.jahani@uottawa.ca.ORCID 0000-0003-4002-3381
University of Ottawa · CAMcGill Genome Centre · CAOttawa Hospital · CAThe University of Melbourne · AURoche (Switzerland) · CH

Funding

Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2016-00605Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2018-05962Canadian HIV Trials Network, Canadian Institutes of Health Research (CTN, CIHR) PJG-185800Canadian HIV Trials Network, Canadian Institutes of Health Research (CTN, CIHR) PJT-159619
6 · The paper itself

Abstract

The plant homeodomain zinc-finger protein, PHF6, is a transcriptional regulator, and PHF6 germline mutations cause the X-linked intellectual disability (XLID) Börjeson-Forssman-Lehmann syndrome (BFLS). The mechanisms by which PHF6 regulates transcription and how its mutations cause BFLS remain poorly characterized. Here, we show genome-wide binding of PHF6 in the developing cortex in the vicinity of genes involved in central nervous system development and neurogenesis. Characterization of BFLS mice harbouring PHF6 patient mutations reveals an increase in embryonic neural stem cell (eNSC) self-renewal and a reduction of neural progenitors. We identify a panel of Ephrin receptors (EphRs) as direct transcriptional targets of PHF6. Mechanistically, we show that PHF6 regulation of EphR is impaired in BFLS mice and in conditional Phf6 knock-out mice. Knockdown of EphR-A phenocopies the PHF6 loss-of-function defects in altering eNSCs, and its forced expression rescues defects of BFLS mice-derived eNSCs. Our data indicate that PHF6 directly promotes Ephrin receptor expression to control eNSC behaviour in the developing brain, and that this pathway is impaired in BFLS.

Indexed as

EpilepsyGrowth DisordersHypogonadismIntellectual DisabilityObesityX-Linked Intellectual DisabilityAnimalsFaceFingersHumansMiceRepressor ProteinsTranscription FactorsPHF6 protein, humanPhf6 protein, mouseRepressor ProteinsTranscription FactorsBFLSEphrin ReceptorsIntellectual DisabilityNeural Stem CellsPHF6

Identifiers

PMID38429579
PMCPMC10933485
OpenAlexW4392360606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.